Sakar Healthcare Share Price

Sakar Healthcare Share Price

NSE: SAKAR
|
Pharmaceuticals
|
S Cap
₹ 1,187.30
-₹1.10 (-0.09%)
1D
Last updated 23 Sep, 2026, 10:40 IST

Sakar Healthcare Share Price Today

As of 23 Sep 2026, Sakar Healthcare share price is ₹1,187.30. The stock opened at ₹1,198.00, compared to its previous close of ₹1,188.40. During today's trading session, Sakar Healthcare share price moved in the range of ₹1,176.05 to ₹1,229.85, with an average price of ₹1,202.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹333.50 and a high of ₹1,229.85. On the performance front, Sakar Healthcare share price has increased by 123.80% over the last six months and is up 243.02% on a year-on-year basis.

₹1,176.05
0.09% down today
₹1,229.85
1D LOW
1D HIGH

Sakar Healthcare Returns Calculator

Circuit
L
H
₹950.75
₹1,426.05
52-week
L
H
₹333.50
₹1,229.85

About Sakar Healthcare

Sakar Healthcare Share Price
ISIN
INE732S01012
Sector Market Cap
₹ 2,644.18 Cr

Sakar Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. It operates in over 50 countries globally and has approximately 292 registered products. It exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.

Sakar Healthcare Financial Highlights

  • Revenue: Sakar Healthcare reported revenue of ₹254.03 crore in FY26 vs ₹178.89 crore in FY25. It showed an increase of 42.00% on a yearly basis.
  • Operating Profit: Sakar Healthcare reported an operating profit of ₹39.76 crore in FY26 vs ₹21.53 crore in FY25. It showed an increase of 84.67% on a year-on-year basis.
  • Net Profit: Sakar Healthcare reported a net profit of ₹30.48 crore in FY26 vs ₹17.50 crore in FY25. It showed an increase of 74.17% on a yearly basis.

Sakar Healthcare Quarterly Result Highlights

  • Sakar Healthcare reported revenue of ₹74.51 crore in Jun 2026, compared with ₹71.27 crore in Mar 2026, representing an increase of 4.55% on a quarter-on-quarter (QoQ) basis.
  • Sakar Healthcare reported an operating profit of ₹14.58 crore in Jun 2026, compared with ₹18.06 crore in Mar 2026, representing a decrease of 19.27% on a quarter-on-quarter (QoQ) basis.
  • Sakar Healthcare reported a profit of ₹10.28 crore in Jun 2026, compared with ₹11.02 crore in Mar 2026, reflecting a decrease of 6.72% on a QoQ basis.
  • The earnings per share (EPS) of Sakar Healthcare stood at ₹13.70 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
52.52%
FII
12.14%
Other DII
11.37%
Retail and other
23.98%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202513.31%
Dec 202513.05%
Mar 202612.94%
Jun 202612.14%
Mkt Cap Cr
2,577.54
P/E
73.27
P/B
8.15
ROE
9.40%
D/E
0.17
ROCE
12.54%
Div. Yield
0.00%
EPS(TTM)
13.70
Turnover
0.57
EV/EBITDA
32.74
Net Margin
12.11%
Op. Margin
28.28%
ROA
7.50%
Quick Ratio
0.64
Curr. Ratio
1.64
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Sakar Healthcare outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Sakar Healthcare appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Sakar Healthcare revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sakar Healthcare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹251.74₹177.58₹153.35₹133.36
Other Income₹2.29₹1.31₹3.18₹4.67
Total Revenue₹254.02₹178.90₹156.53₹138.03
Total Expenses₹214.27₹157.32₹140.63₹121.15
Profit Before Tax₹39.76₹21.53₹15.90₹16.88
Tax₹9.27₹4.03₹4.23₹4.12
Profit After Tax₹30.48₹17.50₹11.67₹12.76
EPS - Basic₹13.70₹7.97₹5.63₹6.75
EPS - Diluted₹13.70₹7.95₹5.63₹6.75

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹39.76₹21.53₹15.90₹16.88
Income before WC changes₹70.56₹50.49₹40.80₹37.01
Change in Assets-₹61.05-₹17.29-₹18.76-₹9.01
Change in Liabilities₹43.75₹3.21₹119.78₹9.60
Change in WC-₹17.29-₹14.08₹101.03₹0.60
Cash flow from Operations₹49.26₹34.03₹24.47₹33.34
Cash flow from Investing-₹28.35-₹30.71-₹51.54-₹74.38
Cash flow from Financing-₹20.96-₹3.48₹27.44₹41.10
Total Cash Flow-₹0.05-₹0.16₹0.37₹0.06
Cash (Start of the year)₹0.31₹0.47₹0.09₹0.03
Cash (End of the year)₹0.26₹0.31₹0.47₹0.09

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹340.55₹326.53₹317.05₹280.42
Current Assets₹140.46₹88.73₹71.61₹55.92
Total Assets₹481.01₹415.26₹388.66₹336.34
Current Liabilities₹109.54₹63.19₹59.06₹54.49
Net Current Asset₹30.92₹25.54₹12.55₹1.42
Non-Current Liabilities₹47.02₹66.60₹67.27₹108.50
Equity Capital₹324.45₹285.48₹262.33₹173.35
Total Equity & Liabilities₹481.01₹415.26₹388.66₹336.34

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹251.74₹177.58₹153.35₹133.36
Other Income₹2.29₹1.31₹3.18₹4.67
Total Revenue₹254.02₹178.90₹156.53₹138.03
Total Expenses₹214.27₹157.32₹140.63₹121.15
Profit Before Tax₹39.76₹21.53₹15.90₹16.88
Tax₹9.27₹4.03₹4.23₹4.12
Profit After Tax₹30.48₹17.50₹11.67₹12.76
EPS - Basic₹13.70₹7.97₹5.64₹6.75
EPS - Diluted₹13.70₹7.95₹5.63₹6.75

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹39.76₹21.53₹15.90₹16.88
Income before WC changes₹70.56₹50.49₹40.80₹37.01
Change in Assets-₹61.05-₹17.29-₹18.76-₹9.01
Change in Liabilities₹43.75₹3.21₹5.57₹9.60
Change in WC-₹17.29-₹14.08-₹13.18₹0.60
Cash flow from Operations₹49.26₹34.03₹24.47₹33.34
Cash flow from Investing-₹28.35-₹30.71-₹51.54-₹74.38
Cash flow from Financing-₹20.96-₹3.48₹27.44₹41.10
Total Cash Flow-₹0.05-₹0.16₹0.37₹0.06
Cash (Start of the year)₹0.31₹0.46₹0.09₹0.03
Cash (End of the year)₹0.26₹0.31₹0.46₹0.09

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹340.56₹326.54₹317.06₹280.43
Current Assets₹140.53₹88.80₹71.69₹55.99
Total Assets₹481.09₹415.35₹388.74₹336.42
Current Liabilities₹109.54₹63.19₹59.06₹54.49
Net Current Asset₹31.00₹25.62₹12.63₹1.50
Non-Current Liabilities₹47.02₹66.60₹67.27₹108.50
Equity Capital₹324.54₹285.56₹262.42₹173.43
Total Equity & Liabilities₹481.09₹415.35₹388.74₹336.42
* All values are in INR Crore
Qty
Bid
1
1185.75
1
1185.6
1
1185.55
1
1185.5
1
1185.45
Ask
Qty
1187.1
1
1187.15
1
1187.2
14
1187.25
1
1187.3
14
Bid Total: 5
Ask Total: 31
Buy orders: 14%
Sell orders: 86%
Bearish
3
Neutral
4
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
68.67
Neutral
ATR (14)
73.91
Neutral
STOCH(9,6)
79.06
Bearish
STOCH RSI (14)
36.37
Neutral
ADX(9)
39.08
Bearish
UO(9)
55.96
Neutral
ROC(12)
18.02
Bullish
WillR(14)
-14.46
Bearish
Period
Simple value
Exponential vaue
5D
1152.32
1161.06
10D
1148.52
1131.46
20D
1049.23
1074.3
50D
952.22
974.06
100D
858.57
867.87
Volume trend — traded volume by day
23 Sep1L
22 Sep1L
21 Sep1L
18 Sep1L
17 Sep0L
16 Sep1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Sakar Healthcare Share Price
Sakar Healthcare
Pharmaceuticals
Add Stock
Add Another

Sakar Healthcare Share Price FAQs

Sakar Healthcare share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837